9th Annual Biomarkers Congress

Drug Design: Roche AG

Total Score People Score Events Score
59 50 50
Date Event Presentation Speakers
June 23, 2010 Structure-Based Drug Design TABLE 5: Why Aren’t We Designing the Perfect Drug as Soon as We Have a Crystal Structure? Rama K. Kondru
Mutation Data Driven Binding Modes for CCR5 Antagonists: Applications in Structure Based Design Rama K. Kondru
Beyond Growing and Linking: Impact of Fragments on the Discovery of Kinas e Inhibitors Andreas Kuglstatter
April 28, 2010 HCV Drug Discovery Structure-Based Design of Non-Nucleoside NS5B Inhibitors for the Treatment of HCV Francisco Talamas
February 24, 2010 5th Annual Bioanalysis in Clinical Research Update on the latest regulatory developments in bioanalysis method validation and study conduct Berthold Lausecker
Interactive panel discussion: Regulated bioanalysis - focus on support of clinical studies Berthold Lausecker
November 13, 2009 Globalization and standardization: Agreements-Budget-Regulation-Operations. New Presentation Edmund Tsuei
November 3, 2009 ASAP-CHI Bio-Pharma Alliance Summit, Driving success with Effect ive Biotech/ Pharma Alliances The Evolution of a BioPharma Partnership - From Technology Platform to Drug Discovery & Development Gad Bitton
July 1, 2009 Advances in Oral Dose Manufacturing PAT and its Application to Solid Oral Dose Production Michel Ulmschneider
June 9, 2009 RNAi for Target Identification and Validation I. Surveying RNAi Opportunities: From Tools to Therapies Thomas Singer
May 12, 2009 BioAvailability and BioEquivalence In silico Prediction Neil John Parrott
April 7, 2009 Inaugural HIV Inhibitors Dual Inhibition of Both HIV and HCV Replication by Novel 2’-Deoxy-Nucleoside Analogs Klaus Klumpp
Binders to HIV-1 RT: Approaches to Improve Mutant Profile and Oral Bioavailability Todd Elworthy
April 6, 2009 Fourth Annual FRAGMENT-BASED DRUG DISCOVERY Impact of Fragment Screening on the Rapid Discovery of Novel and Selective Protein Kinase Inhibitors Andreas Kuglstatter
March 3, 2009 2nd annual Competitive Intelligence in Pharma CASE STUDY: Discussing the successes and failures of CI Christopher Perkins
Roundtable sessions : Incorporating Market Research into the CI Process Christopher Perkins
February 24, 2009 Pharmaceutical Analysis Course Promoting pharmaceutical excellence: Advanced data analysis for process understanding Michel Ulmschneider
February 23, 2009 2nd Annual Latin America Clinical Trials Developing Strategies for Regional Site Selection and Improvement in Clinical Trial Methodology Daniel Ciriano
February 23, 2009 Advances and Progress in Drug Design VIII SCREENING TECHNOLOGIES AND STRUCTURE BASED DESIGN Michael Hennig
February 9, 2009 Immunogenicity for Biologics 2009 A concerted and staggered implementation of different assays and methods for antibody screening and characterisation Julia Schleypen
February 3, 2009 Ramanbhai Foundation 4th International Symposium ---Ramanbhai Foundation 4th International Symposium--- “Advances in Cardiometabolic Research - Basic Science and Clinical Aspects” Current understanding of the off-target activity of torcetrapib” Eric J. Niesor
January 28, 2009 Electronic Laboratory Notebooks SYSTEMS INTEGRATION : Integrating systems and streamlining the research process Michael Braxenthaler
January 27, 2009 4th Annual Aseptic Filling and Processing Case study 1 | Implementation of 9 isolators in highly active facilities for semi-solid and parenteral drug products: multiple purpose concept, decision criteria and main project phases. Dieter Roethlisberger
January 26, 2009 Biomarker Assay Development Biomarker and Companion Diagnostics Assay Development: An IVD Perspective Thomas Li
January 5, 2009 High Content Analysis Advanced Workshop Part II: Assay Development Ann F Hoffman
Data Management in the HCAWorld Keith Grochow
December 2, 2008 2nd Annual:Outsourcing Preclinical Development Large pharmaceutical strategies for performance management Martin Bopst,
December 2, 2008 2nd Annual: Pre-clinical and clinical safety testing for new drugs Reactive metabolite assessment in drug discovery and early development as an integral part of drug safety: Minimising the risk for idiosyncratic liver toxicity Axel Pahler,
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 1: The application of near-infrared optical imaging in preclinical cancer research Werner Scheuer,
2 : MRI (magnetic resonance imaging) of animal models in preclinical research Basil Künnecke,
December 2, 2008 The 8th World Drug Discovery & Development Summit 2008 NEW STRATEGIES TO IDENTIFY SAFETY LIABILITIES EARLY Thomas Singer
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance Updates on what to expect when regulators conduct GCP and pharmacovigilance inspections: Case study on MHRA (UK), BfArM (Germany), PMDA (Japan), IMB (Ireland), SUKL (Czech Republic), AGEMED (Spanish), EMEA (Europe) Nick Phillips,
Essential update on inspector requirements: quality management systems with a risk based approach - how can this be implemented? Peter Schiemann,
November 20, 2008 5TH LATIN AMERICAN CONGRESS OF CLINICAL RESEARCH REGIONAL PERSPECTIVES AND FUTURE TRENDS B) Risk management. Concepts of Global Quality Risk Management / Creating a QRM environment cross-functionally for Clinical Trials. Gabriele Roth
November 17, 2008 BIO-Europe 2008 Early Stage Dealmaking – How to Build Value Instead of Giving it Away Sarah Holland
November 5, 2008 DIA's 6th Canadian Annual Meeting: Benefit and Risk Management: An Evolution in Progress TRACK 3 : THE INDUSTRY PERSPECTIVE Jane Shum
October 28, 2008 Bridging Pharma and IT Kinase Data Mart: Browsing and Shopping for Kinase Data Hans Bitter, Rama K. Kondru
September 17, 2008 BACULOVIRUS TECHNOLOGY Application of Baculovirus in GPCR and Ion Channel Protein Expression in Mammalian Cells Simon Lee
August 19, 2008 Enabling Point-of-Care Diagnostics Expert Panel: REGULATORY GUIDANCE AND REIMBURSEMENT ISSUES Kathleen Claessens
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application Novel GPCR Drugs in the Clinic Vincent Mutel
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application (E2) Novel GPCR Drugs in the Clinic Vincent Mutel
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Elective: Track A: Collaborations & Partnerships: Effective Partnerships: Working with Academic Centers in China Yun He
March 25, 2008 Preclinical Development From Publication to Practice: Interlaboratory Validation of Microarray and QPCR-based Signatures for Predicting Carcinogenicity in the Rat Mark Fielden
March 25, 2008 TRENDS IN DRUG SAFETY From Publication to Practice: Interlaboratory Validation of Mark Fielden
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION D: SCIENTIFIC WRITING AND THE PUBLICATION PROCESS Tom Curran
Dealing with the Necessary Evils: Editors and Reviewers Tom Curran
Targeting the Hedgehog Pathway in Pediatric Brain Tumors Tom Curran
February 19, 2008 ADMET Europe Towards a Multidimensional Optimization in the Field of ADME-Tox: Strategies & Case Studies Holger Fischer
February 18, 2008 Fragment-based Lead Discovery Conference Fragment screening of drug targets by SPR and subsequent X-ray structural analysis Michael Hennig
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Nils Heldt
PRECLINICAL DEVELOPMENT AND CHALLENGES: INTERACTIVE PANEL :Partnership and Outsourcing Deals in India – Successes and Failures (17:00-17:45) Nils Heldt
MANAGING GLOBAL ALLIANCES FOR SUCCESS: A New Roche Collaboration: Partnering in India and Identifying the Right Candidate to Sup-port Clinical Development Operations (15:30-16:00) Nils Heldt
November 5, 2007 Bio-Pharma Alliance Summit Nov (05-06) "Building Alliance Flexibility to Enhance Value“: The Enhanze Technology Partnership Between Roche and Halozyme Therapeutics (11:20-1200) Louk Pechtold
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 2: Ultra-High Throughput Sequencing Technologies: Towards Patient Genome Sequencing Michael EGHOLM
Concurrent Session 5: Advances in Cancer Therapeutics Michael EGHOLM
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies: RNAi Screening to Identify and Validate Therapeutic Targets in Metabolic Diseases (08:40-09:10) John Reidhaar-Olson
In vitro RNAi Screening Strategies (08:30-10:40) John Reidhaar-Olson
In vitro RNAi Screening Strategies: Chairperson’s Remarks (08:30-08:40) John Reidhaar-Olson
Roundtable Discussion Topic: In vitro RNAi Screening (07:30-08:30) John Reidhaar-Olson
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Wolfgang Guba
PROFILING TO OPTIMIZE EFFICACY: Case Study - Chemogenomic Strategies for GPCR Hit Finding (11:15-11:45) Wolfgang Guba
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Rebecca A. Taub
October 2, 2007 IVT 's Lab Week The Tools for Detecting Trends | Track D Compliant Data & Documentation for the Laboratory Michael Nolchen
Trend Analysis in QC of Marketed Products | Track D Compliant Data & Documentation for the Laboratory Michael Nolchen
Interactive Exercise | Track D Compliant Data & Documentation for the Laboratory Michael Nolchen
Interactive Exercise | Track D Compliant Data & Documentation for the Laboratory Michael Nolchen
September 24, 2007 12th Annual Drug Delivery Technologies & Deal Making Keynote Presentation: Flexibility in Alliances Frank Grams
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY: Proteomic Analysis of Protein-Protein Interaction for Identification of Membrane Markers of Disease (11:30-12:00) Jinzhi Chen
Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY (08:30-16:00) Jinzhi Chen
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities Interactive Panel Discussion#3 (11:30-12:15) Edmund Tsuei
CASE STUDY: Place of China in Global Drug Development Strategy (14:15-14:45) Edmund Tsuei
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.